Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Organon & Co. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 636 | 14 | 610 | −12 |
| Shares | 198.8M | 38.0M | 199.8M | +39.0M (+24.3%) |
| Value | $1.43B | $272.8M | $1.20B | +$45.7M (+4.0%) |
14 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (81)
Institutions that held Organon & Co. at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (93)
Institutions that held Organon & Co. at the end of Q4 2025 and filed for Q1 2026 without it.
Not filed for Q1 2026 yet (14)
Institutions that held Organon & Co. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 36,916,382 | $264.7M |
| Beddow Capital Management Inc | 666,725 | $4.78M |
| Norges Bank | 264,857 | $1.90M |
| CIBC World Markets Corp | 102,986 | $738.4K |
| Comerica Bank | 68,972 | $494.5K |
| EMC Capital Management | 15,167 | $109.0K |
| CIBC Private Wealth Group, LLC | 6,078 | $43.6K |
| Global Retirement Partners, LLC | 2,292 | $16.4K |
| Trust Co of Vermont | 1,110 | $7.96K |
| ORG Partners LLC | 389 | $2.79K |
| Maryland Capital Advisors Inc. | 250 | $1.79K |
| Northwest Capital Management Inc | 146 | $1.05K |
| Ransom Advisory, Ltd | 46 | $330 |
| Motiv8 Investments LLC | 2 | $0 |